Treatment of tumors by selective protein depletion

Details Treatment of tumors by selective protein depletion Treatment of tumors by selective protein depletion

A - Human Necessities

61

M

A61M 1/38 (2006.01) A61K 31/195 (2006.01) A61K 31/40 (2006.01) A61K 31/415 (2006.01) A61K 35/14 (2006.01) A61M 1/34 (2006.01) A61M 1/36 (2006.01) A61M 5/142 (2006.01) A61M 5/145 (2006.01)

Patent

CA 2146754

The invention describes a method of treatment of tumors based on a fundamental dynamic difference between the normal and tumor cells, which underscores the very danger of tumors - their propensity to grow and proliferate under conditions where normal cells would not do so. The preferred mode of treatment is by extracorporeal blood conditioning, whereby the concentration of one of the (essential) amino acids is the control parameter. The blood is passed through a filter where the blood cells and the high molecular weight constituents are separated from a plasma fraction containing low molecular weight substances, including amino acids. The fraction with low molecular weight substances is reacted against either adsorption or decomposing agents and returned to the blood. The filtration is done to decrease the concentration - increase is controlled by simply injecting the amino acid. A single treatment session includes at least four phases whereby the concentration is first decreased (collecting all cells in the G0 phase); then increased (pushing the tumor cells over restriction point); then decreased to minimnm level possible (killing the tumor cells); and finally normalized.

Procédé de traitement de tumeurs fondé sur une différence dynamique foncière entre les cellules normales et les cellules tumorales, différence qui souligne la gravité même des tumeurs, à savoir leur tendance à se développer et à proliférer dans des conditions où le développement et la prolifération des cellules normales seraient impossibles. Le mode préféré de traitement comprend le conditionnement extracorporel du sang, la concentration de l'un des acides aminés (indispensables) étant le paramètre de référence. On fait passer le sang dans un filtre, et les globules sanguins et les constituants à poids moléculaire élevé se séparent d'une fraction plasmatique renfermant les substances à faible poids moléculaire, notamment les acides aminés. On met en réaction la fraction renfermant les substances à faible poids moléculaire, avec des agents d'adsorption ou de décomposition, puis on la remet en circulation dans le sang. La filtration sert à diminuer la concentration; on règle l'augmentation tout simplement en injectant l'acide aminé. Chaque séance de traitement comprend au moins quatre phases: réduction de la concentration (regroupement de toutes les cellules dans la phase G0); augmentation de la concentration (dépassement du point de restriction par les cellules tumorales); réduction de la concentration jusqu'à sa valeur la moins élevée possible (afin de tuer les cellules tumorales); et enfin normalisation.

Affiliated with

Also associated with

Rating

Treatment of tumors by selective protein depletion does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of tumors by selective protein depletion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tumors by selective protein depletion will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1883050